Ascend Wellness Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	516.04	561.6	518.59	405.93	332.38	143.73
Revenue Growth (YoY)	-8.79%	8.29%	27.76%	22.13%	131.25%	1094.58%
Cost of Revenue	344.62	377.39	361.9	271.36	196.41	82.82
Gross Profit	171.43	184.21	156.69	134.56	135.97	60.91
Selling, General & Admin	128.37	144.48	129.43	122.43	106.02	44.87
Other Operating Expenses	-	-	-22.79	-	-	-
Operating Expenses	165.09	179.46	136.17	136.52	116.06	52.78
Operating Income	6.34	4.75	20.52	-1.96	19.91	8.13
Interest Expense	-47.52	-45.26	-36.98	-32.44	-63.99	-12.99
Other Non Operating Income (Expenses)	0.91	0.71	3.05	0.76	0.26	0.01
EBT Excluding Unusual Items	-40.27	-39.81	-13.42	-33.64	-43.82	-4.85
Merger & Restructuring Charges	-	-	-	-0.22	-	-
Gain (Loss) on Sale of Assets	-0.08	-0.02	0.23	-0.35	-0.61	-0.29
Legal Settlements	-	-	-	-5	-36.51	-
Other Unusual Items	-	-	-1.57	-	-	-
Pretax Income	-40.35	-39.82	-14.76	-39.21	-80.94	-5.14
Income Tax Expense	45.93	45.17	33.45	41.69	41.72	18.7
Earnings From Continuing Operations	-86.28	-84.99	-48.21	-80.9	-122.66	-23.84
Minority Interest in Earnings	-	-	-	-	-	-1.6
Net Income	-86.28	-84.99	-48.21	-80.9	-122.66	-25.44
Net Income to Common	-86.28	-84.99	-48.21	-80.9	-122.66	-25.44
Shares Outstanding (Basic)	206	212	199	183	149	95
Shares Outstanding (Diluted)	206	212	199	183	149	95
Shares Change (YoY)	-2.14%	6.67%	8.60%	22.72%	57.03%	9.02%
EPS (Basic)	-0.42	-0.40	-0.24	-0.44	-0.82	-0.27
EPS (Diluted)	-0.42	-0.40	-0.24	-0.44	-0.82	-0.27
Free Cash Flow	32.76	50.76	51.09	-120	-130.17	-32.42
Free Cash Flow Per Share	0.16	0.24	0.26	-0.65	-0.87	-0.34
Gross Margin	33.22%	32.80%	30.21%	33.15%	40.91%	42.38%
Operating Margin	1.23%	0.85%	3.96%	-0.48%	5.99%	5.66%
Profit Margin	-16.72%	-15.13%	-9.30%	-19.93%	-36.90%	-17.70%
Free Cash Flow Margin	6.35%	9.04%	9.85%	-29.56%	-39.16%	-22.56%
EBITDA	47	41.99	51.28	14.05	30.61	16.05
EBITDA Margin	9.11%	7.48%	9.89%	3.46%	9.21%	11.16%
D&A For EBITDA	40.66	37.24	30.76	16.01	10.7	7.91
EBIT	6.34	4.75	20.52	-1.96	19.91	8.13
EBIT Margin	1.23%	0.85%	3.96%	-0.48%	5.99%	5.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.